Can Novo Nordisk’s GLP-1 Pill Momentum Offset LLY’s Growing Edge?
Novo Nordisk NVO remains a dominant player in the GLP-1 market, marketing its semaglutide drugs Ozempic and Rybelsus for…
Four EU countries push Brussels to ease carbon market pressure on industry
Four European Union countries are urging the European Commission to rethink part of its planned carbon market reforms,…
Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk
Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk Proactive uses images…
Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk
Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk Proactive uses images…
Novo Nordisk cuts GLP-1 prices as pressure builds on obesity juggernaut
Inside Biotech: Novo Nordisk cuts GLP-1 prices as pressure builds on obesity juggernaut Proactive uses images sourced from…